Drug Trial Radar · NCT02805023
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
Last checked: Nov 19, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jun 2016
Primary completion
Jul 2017
Study completion Dec 2027
Sponsor
- Lead sponsor
- BioGenCell Ltd.Biogen (BIIB)
- Sponsor type
- Industry
- Collaborators
- Laniado Hospital; Rabin Medical Center
- First posted
- Jun 17, 2016
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the feasibility of an autologous cell preparation composed of a mixture of cells enriched for endothelial progenitor cells (EnEPCs) and multipotent adult hematopoietic stem/progenitor cells (HSPC) (BGC101), in the treatment of patients suffering from peripheral arterial disease (PAD) with critical limb ischemia (CLI) who have not responded to optimal pharmacological treatment or control of risk factors and/or had a revascularization failure, and do not have the option of further revascularization treatment.
Conditions
- Chronic Limb-Threatening Ischemia
- Peripheral Arterial Disease
- Peripheral Vascular Disease
Interventions
BGC101 (autologous EnEPC preparation)Biological
Intramuscular injections - single treatment session
Control mediumBiological
Intramuscular injections - single treatment session
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety (Incidence of adverse events)Time frame: 12 Months
- Efficacy (Improvement of indication signs)Time frame: 12 Months
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
University of San Francisco
San Francisco, California
Yale University School of Medicine
New Haven, Connecticut
Johns Hopkins Hospital
Baltimore, Maryland
Rambam Health Care Campus
Haifa, Israel
Laniado Hospital
Netanya, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.